India Business Forum

Search Button

The Indian Express

The Financial Express

Latest News

EIW

Market Indicators

Screen

Celebrity Chat

Express Computers

Express Power

Advertisers Forum

Express Careers

Business Forum

Match Maker

Express Properties

Palki - Travel & Tours

Information Technology

Astrosurf

Eco-India

Dr Know

Morning Digest

Graffiti

Crossword

Drumbeat: Ad Buzzaar


Corporate

Economy

Expressions

Markets

Leisure

 

Monday, August 17, 1998

Ibuprofen recovers after a lull 

Nitya Varadarajan  
Prices of anti-inflammatory generic drug, Ibuprofen are picking up in both domestic and international markets after a depressed period during January this year.

The drug is now tentatively climbing up to the price levels of April 1996 - April 1997 period. Price in the domestic market has gone up from Rs 410/kg to Rs 446/kg between April and June 1998. Export prices to non-US countries have risen from $8 per kg to $9.5 per kg for the same period and to the US, it stands at round $13 per kg.

The global demand for Ibuprofen is estimated to be 8000 tpa while domestic demand is around 1500 tpa. The present price recommendation for Ibuprofen by National Pharmaceutical Pricing Authority (NPPA) is Rs 442/kg.

The drug price in the domestic market is generally volatile showing wide variations. Any increase in prices beyond Rs 400 per kg attracts a host of manufacturers from Hyderabad leading to excess supply and lowering of prices. This price sensitivity acts as a deterrent for new players to set up a greenfieldproject for Ibuprofen. An average 2500 tpa project would cost Rs 75 crore.

One of the largest players of Ibuprofen in the country is Shasun Chemicals and Drugs Ltd. An increase in the export commitments of Shasun leads to depletion of supplies to the domestic market resulting in corresponding price increases. Shasun exports to USA, Middle East and the Asian countries.

It supplies Ibuprofen to leading multinationals around the world including Boots Pharmaceuticals, the original patent holder. Currently it has a capacity to manufacture 2500 tonnes per annum (started with 60 tpa in 1986), making it one of the largest producers in the world. The company first got FDA approval for exports from its Pondicherry plant in 1991 which was extended in 1996.

Despite the availability of Naproxen as an alternative to Ibuprofen, the latter still enjoys a considerable popularity the world over on account of its price advantage. Manufacturers of Ibuprofen have as a result objected to sodium metal, a critical raw materialfor Ibuprofen manufacture being placed in the restricted category of imports from April 1997. A specific import license has to be obtained from the Director General of foreign Trade, ministry of commerce, New Delhi for import of the material.

Being in the restricted category creates difficulties in the opening of an import letter of credit without the licence. As there is only one manufacturer of sodium metal here who does not have the capacity to service the requirements of the Ibuprofen industry, the input should be reverted to the OGL category with actual user condition.

Copyright © 1998 Indian Express Newspapers (Bombay) Ltd.


Top


The Ambassador Group of Hotels

Global Tenders invited by MSTC

The National Stock Exchange of India (NSE)

 

Click here for a printer-friendly page Printer-friendly page

An independent investment information and credit rating agency


The Indian Express  |  The Financial Express  |  Latest News
Screen  |  Express Investment Week  |  Market Indicators  |  Express Computers
Astrosurf  |  Eco-India  |  Travel & Tourism  |  Information Technology  |  Drumbeat: Ad Buzzaar
Advertisers Forum  |  Career India  |  Business Forum  |  Match Maker  |  Express Properties